| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.50.6.1722 |
| P8608 | Fatcat ID | release_vig46pt4fzbx3fo5n4glxm6pea |
| P698 | PubMed publication ID | 9633717 |
| P2093 | author name string | Clark WM | |
| Coull BM | |||
| Sexton G | |||
| Beamer NB | |||
| Wynn M | |||
| Briley DP | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1722-1728 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Persistent inflammatory response in stroke survivors | |
| P478 | volume | 50 |
| Q36539414 | A preliminary method development study to identify potential stroke biomarkers in plasma using multiple chromatographies with nanoLC-ESIMS detection |
| Q30998860 | A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease |
| Q37854983 | Association of atherosclerotic risk factors with carotid adventitial thickness assessed by ultrasonography. |
| Q33276036 | Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production |
| Q36598022 | Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. |
| Q35849721 | Exploratory Cohort Study of Associations between Serum C - Reactive Protein and Fatigue after Stroke |
| Q48708439 | Fibrinogen, stroke, and obstructive sleep apnea: an evolving paradigm of cardiovascular risk |
| Q35022584 | Glucocorticoids and central nervous system inflammation |
| Q34277735 | Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke |
| Q48118212 | Increased cytokine release from peripheral blood cells after acute stroke. |
| Q38991032 | Injury site-specific targeting of complement inhibitors for treating stroke |
| Q49145776 | Interaction of indomethacin with cytokine production in whole blood. Potential mechanism for a brain-protective effect |
| Q33260505 | Levels of acute phase proteins remain stable after ischemic stroke |
| Q34015050 | Lipoprotein (a) and stroke |
| Q44736902 | Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke |
| Q34604324 | Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease |
| Q48410374 | Plasma concentrations of C-reactive protein and fibrinogen in ischaemic stroke |
| Q47928149 | Preoperative high leukocyte count: a novel risk factor for stroke after cardiac surgery |
| Q35483503 | Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. |
| Q38449685 | Randomized controlled pilot study of a SystemCHANGE™ weight management intervention in stroke survivors: rationale and protocol |
| Q36134214 | Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis |
| Q35071925 | Research on the relationship between fibrinogen level and subtypes of the TOAST criteria in the acute ischemic stroke |
| Q48165581 | Selenoprotein S expression in the rat brain following focal cerebral ischemia |
| Q40524803 | Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients |
| Q34729372 | Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume |
| Q27001147 | Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date |
| Q36567334 | Sustained inflammation 1.5 years post-stroke is not associated with depression in elderly stroke survivors |
| Q38417525 | Systemic inflammation as a therapeutic target in acute ischemic stroke |
| Q74552962 | [C-reactive protein as a coronary risk factor] |
Search more.